169 related articles for article (PubMed ID: 19854117)
1. Development of a high-performance liquid chromatographic-mass spectrometric method for the determination of cellular levels of the tyrosine kinase inhibitors lapatinib and dasatinib.
Roche S; McMahon G; Clynes M; O'Connor R
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Dec; 877(31):3982-90. PubMed ID: 19854117
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic Drug Monitoring of the new targeted anticancer agents imatinib, nilotinib, dasatinib, sunitinib, sorafenib and lapatinib by LC tandem mass spectrometry.
Haouala A; Zanolari B; Rochat B; Montemurro M; Zaman K; Duchosal MA; Ris HB; Leyvraz S; Widmer N; Decosterd LA
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jul; 877(22):1982-96. PubMed ID: 19505856
[TBL] [Abstract][Full Text] [Related]
3. Method development and validation for the quantification of dasatinib, erlotinib, gefitinib, imatinib, lapatinib, nilotinib, sorafenib and sunitinib in human plasma by liquid chromatography coupled with tandem mass spectrometry.
Lankheet NA; Hillebrand MJ; Rosing H; Schellens JH; Beijnen JH; Huitema AD
Biomed Chromatogr; 2013 Apr; 27(4):466-76. PubMed ID: 22987603
[TBL] [Abstract][Full Text] [Related]
4. Sensitive single quadrupole LC/MS method for determination of lapatinib in human plasma.
Musijowski J; Filist M; Rudzki PJ
Acta Pol Pharm; 2014; 71(6):1029-36. PubMed ID: 25745775
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous determination of nine tyrosine kinase inhibitors by 96-well solid-phase extraction and ultra performance LC/MS-MS.
Bouchet S; Chauzit E; Ducint D; Castaing N; Canal-Raffin M; Moore N; Titier K; Molimard M
Clin Chim Acta; 2011 May; 412(11-12):1060-7. PubMed ID: 21345336
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous analysis of anticancer agents bortezomib, imatinib, nilotinib, dasatinib, erlotinib, lapatinib, sorafenib, sunitinib and vandetanib in human plasma using LC/MS/MS.
Andriamanana I; Gana I; Duretz B; Hulin A
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 926():83-91. PubMed ID: 23562906
[TBL] [Abstract][Full Text] [Related]
7. Simple and selective method for the determination of various tyrosine kinase inhibitors used in the clinical setting by liquid chromatography tandem mass spectrometry.
Honeywell R; Yarzadah K; Giovannetti E; Losekoot N; Smit EF; Walraven M; Lind JS; Tibaldi C; Verheul HM; Peters GJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 May; 878(15-16):1059-68. PubMed ID: 20382575
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous determination of methotrexate, dasatinib and its active metabolite N- deshydroxyethyl dasatinib in rat plasma by LC-MS/MS: method validation and application to pharmacokinetic study.
Thappali SR; Varanasi KV; Veeraraghavan S; Vakkalanka SK; Khagga M
Arzneimittelforschung; 2012 Dec; 62(12):624-30. PubMed ID: 23138519
[TBL] [Abstract][Full Text] [Related]
9. Validation and application of a high-performance liquid chromatography-tandem mass spectrometric method for simultaneous quantification of lopinavir and ritonavir in human plasma using semi-automated 96-well liquid-liquid extraction.
Wang PG; Wei JS; Kim G; Chang M; El-Shourbagy T
J Chromatogr A; 2006 Oct; 1130(2):302-7. PubMed ID: 16919649
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of a high-performance liquid chromatography ultraviolet method for lapatinib quantification in human plasma.
Escudero-Ortiz V; Pérez-Ruixo JJ; Valenzuela B
Ther Drug Monit; 2013 Dec; 35(6):796-802. PubMed ID: 23942544
[TBL] [Abstract][Full Text] [Related]
11. Determination of lapatinib (GW572016) in human plasma by liquid chromatography electrospray tandem mass spectrometry (LC-ESI-MS/MS).
Bai F; Freeman BB; Fraga CH; Fouladi M; Stewart CF
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Feb; 831(1-2):169-75. PubMed ID: 16364699
[TBL] [Abstract][Full Text] [Related]
12. Development and clinical application of a LC-MS/MS method for simultaneous determination of various tyrosine kinase inhibitors in human plasma.
Götze L; Hegele A; Metzelder SK; Renz H; Nockher WA
Clin Chim Acta; 2012 Jan; 413(1-2):143-9. PubMed ID: 21945732
[TBL] [Abstract][Full Text] [Related]
13. Imatinib assay by high-performance liquid chromatography in tandem mass spectrometry with solid-phase extraction in human plasma.
Moreno JM; Wojnicz A; Steegman JL; Cano-Abad MF; Ruiz-Nuño A
Biomed Chromatogr; 2013 Apr; 27(4):502-8. PubMed ID: 23034891
[TBL] [Abstract][Full Text] [Related]
14. Liquid chromatography-tandem mass spectrometric assay for therapeutic drug monitoring of the tyrosine kinase inhibitor pazopanib in human plasma.
Sparidans RW; Ahmed TT; Muilwijk EW; Welzen ME; Schellens JH; Beijnen JH
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Sep; 905():137-40. PubMed ID: 22917595
[TBL] [Abstract][Full Text] [Related]
15. Sensitive liquid chromatographic/tandem mass spectrometric method for the determination of beclomethasone dipropionate and its metabolites in equine plasma and urine.
Guan F; Uboh C; Soma L; Hess A; Luo Y; Tsang DS
J Mass Spectrom; 2003 Aug; 38(8):823-38. PubMed ID: 12938103
[TBL] [Abstract][Full Text] [Related]
16. Determination of a novel substance P inhibitor in human plasma by high-performance liquid chromatography with atmospheric pressure chemical ionization mass spectrometric detection using single and triple quadrupole detectors.
Constanzer ML; Chavez-Eng CM; Dru J; Kline WF; Matuszewski BK
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Aug; 807(2):243-50. PubMed ID: 15203036
[TBL] [Abstract][Full Text] [Related]
17. Development, validation and application of a sensitive LC-MS/MS method for the quantification of thalidomide in human serum, cells and cell culture medium.
Roche S; Sewell L; Meiller J; Pedersen K; Rajpal R; O'Gorman P; Clynes M; O'Connor R
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Aug; 902():16-26. PubMed ID: 22771235
[TBL] [Abstract][Full Text] [Related]
18. Dasatinib.
Korashy HM; Rahman AF; Kassem MG
Profiles Drug Subst Excip Relat Methodol; 2014; 39():205-37. PubMed ID: 24794907
[TBL] [Abstract][Full Text] [Related]
19. High-performance liquid chromatographic method for the determination of dasatinib in rabbit plasma using fluorescence detection and its application to a pharmacokinetic study.
Kassem MG; Ezzeldin E; Korashy HM; Mostafa GA
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Nov; 939():73-9. PubMed ID: 24113234
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous quantitative determination of seven novel tyrosine kinase inhibitors in plasma by a validated UPLC-MS/MS method and its application to human microsomal metabolic stability study.
Ezzeldin E; Iqbal M; Herqash RN; ElNahhas T
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Jan; 1136():121851. PubMed ID: 31812004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
